Anavex stock rallies 30% on business updates

Anavex Life Sciences (NASDAQ:AVXL) stock rallied 30% Monday after the company issued its fiscal Q3 earnings report and announced EU regulators had accepted the market application for its Alzheimer’s drug candidate.

The biotech company said the European Medicines Agency has